Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Metastatic Breast Cancer
Interventions
OTHER

For each patient included, the samples described below will be collected:

"* A single blood sample will be taken before initiation of the metastatic treatment line. The volume of total blood sampled is 34mL.~* A tumour sample (FFPE block already archived) from a metastasis (other than bone) if available or, failing this, from the primary breast tumour, will be sent to the sponsor in order to meet the objectives of the study.~Once the blood sample has been taken, patients will have completed their participation in the study."

Trial Locations (1)

31059

RECRUITING

IUCT-O, Toulouse

All Listed Sponsors
collaborator

Fondation Toulouse Cancer Santé

UNKNOWN

lead

Institut Claudius Regaud

OTHER